According to www.techsciresearch.com latest Report- The market for animal pharmaceuticals market is likely to grow with a steady CAGR during the forecast period due to the increase in pet adoption, rise in fatal diseases like Ebola and swine flu spreading from consumption of dairy and animal related products. Report URL- https://www.techsciresearch.com/report/-animal-pharmaceuticals-market/4543.html

1. MARKET INTELLIGENCE . CONSULTING
www.techsciresearch.com
GLOBAL ANIMAL PHARMACEUTICALS MARKET
FORECAST & OPPORTUNITIES
2015 – 2025

2. 2
Scope of Report
Product of Interest (POI): Animal Pharmaceuticals
Review Period
2015 – 2018
Base Year
2019
Estimated Year
2020
Forecast Period
2021 – 2025
Year Range
REGION
• Asia-Pacific
• Europe
• North America
• South America
• Middle East &
Africa (MEA)
Global animal pharmaceuticals market is likely to grow with a steady CAGR during the
forecast period due to increase in pet adoption, rise in fatal diseases like Ebola and swine
flu spreading from consumption of dairy and animal related products. Animal
pharmaceuticals are highly beneficial in diagnosis and treatment of animal disorders. Based
on product type, market can be segregated into vaccine, veterinary and others.
Market Segmentation
PRODUCT TYPE
• Vaccine
• Veterinary
• Others
ANIMAL TYPE
• Companion Animals
• Production Animals
• Generic
• Patented
REGISTRATION
PRODUCT
• Ectoparasiticides
• Endoparasiticides
• Anti-Inflammatories
• Bronchodilators

3. 3
Table of Contents
S. No. Contents Page No.
1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Animal Pharmaceuticals Market
4. Executive Summary
5. Voice of Customers
6. Global Animal Pharmaceuticals Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1. By Product Type (Vaccine, Veterinary, Others)
6.2.2. By Product
6.2.2.1. Ectoparasiticides (Ivermectin, Cypermethrin, Fipronil, Coumaphos, Others)
6.2.2.2.
Endoparasiticides (Ivermectin, Praziquantel, Flubendazole, Milbemycin,
Levamisole, Fenbendazole, Pyrantel, Others)
6.2.2.3. Anti-Inflammatories (NSAIDs, Corticosteroids, Others)
6.2.2.4. Bronchodilators (Theophylline, Albuterol, Others)
6.2.3. By Animal Type (Companion Animals, Production Animals)
6.2.4. By Registration (Generic, Patented)
6.2.5.
By Region (Asia-Pacific, Europe, North America, South America and Middle East &
Africa)

4. 4
Table of Contents
S. No. Contents Page No.
6.2.6. By Company (2019)
6.3. Market Attractiveness Index
7. Asia-Pacific Animal Pharmaceuticals Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Product
7.2.3. By Animal Type
7.2.4. By Country (China, India, Japan, South Korea, Australia)
7.3. Asia-Pacific: Country Analysis
7.3.1. China Animal Pharmaceuticals Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value & Volume
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product Type
7.3.1.2.2. By Product
7.3.1.2.3. By Animal Type
7.3.2. India Animal Pharmaceuticals Market Outlook

5. 5
Table of Contents
S. No. Contents Page No.
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value & Volume
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product Type
7.3.2.2.2. By Product
7.3.2.2.3. By Animal Type
7.3.3. Japan Animal Pharmaceuticals Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value & Volume
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product Type
7.3.3.2.2. By Product
7.3.3.2.3. By Animal Type
7.3.4. South Korea Animal Pharmaceuticals Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value & Volume
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product Type
7.3.4.2.2. By Product
7.3.4.2.3. By Animal Type

6. 6
Table of Contents
S. No. Contents Page No.
7.3.5. Australia Animal Pharmaceuticals Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value & Volume
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product Type
7.3.5.2.2. By Product
7.3.5.2.3. By Animal Type
8. Europe Animal Pharmaceuticals Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value & Volume
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Product
8.2.3. By Animal Type
8.2.4. By Country (United Kingdom, Italy, France, Germany, Spain)
8.3. Europe: Country Analysis

7. 7
Table of Contents
S. No. Contents Page No.
8.3.1. United Kingdom Animal Pharmaceuticals Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value & Volume
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product Type
8.3.1.2.2. By Product
8.3.1.2.3. By Animal Type
8.3.2. Italy Animal Pharmaceuticals Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value & Volume
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product Type
8.3.2.2.2. By Product
8.3.2.2.3. By Animal Type
8.3.3. France Animal Pharmaceuticals Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value & Volume
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product Type
8.3.3.2.2. By Product

8. 8
Table of Contents
S. No. Contents Page No.
8.3.3.2.3. By Animal Type
8.3.4. Germany Animal Pharmaceuticals Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value & Volume
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product Type
8.3.4.2.2. By Product
8.3.4.2.3. By Animal Type
8.3.5. Spain Animal Pharmaceuticals Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value & Volume
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product Type
8.3.5.2.2. By Product
8.3.5.2.3. By Animal Type
9. North America Animal Pharmaceuticals Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value & Volume
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Product

9. 9
Table of Contents
S. No. Contents Page No.
9.2.3. By Animal Type
9.2.4. By Country (United States, Canada, Mexico)
9.3. North America: Country Analysis
9.3.1. United States Animal Pharmaceuticals Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value & Volume
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product Type
9.3.1.2.2. By Product
9.3.1.2.3. By Animal Type
9.3.2. Canada Animal Pharmaceuticals Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value & Volume
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product Type
9.3.2.2.2. By Product
9.3.2.2.3. By Animal Type
9.3.3. Mexico Animal Pharmaceuticals Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value & Volume
9.3.3.2. Market Share & Forecast

10. 10
Table of Contents
S. No. Contents Page No.
9.3.3.2.1. By Animal Type
10. South America Animal Pharmaceuticals Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value & Volume
10.2. Market Share & Forecast
10.2.1. By Product Type
10.2.2. By Product
10.2.3. By Animal Type
10.2.4. By Country (Brazil, Argentina, Colombia)
10.3. South America: Country Analysis
10.3.1. Brazil Animal Pharmaceuticals Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1 By Value & Volume
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product Type
10.3.1.2.2. By Product
10.3.1.2.3. By Animal Type
10.3.2. Argentina Animal Pharmaceuticals Market Outlook

11. 11
Table of Contents
S. No. Contents Page No.
10.3.2.1. Market Size & Forecast
10.3.2.1.1 By Value & Volume
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product Type
10.3.2.2.2. By Product
10.3.2.2.3. By Animal Type
10.3.3. Colombia Animal Pharmaceuticals Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1 By Value & Volume
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product Type
10.3.3.2.2. By Product
10.3.2.2.3. By Animal Type
11. Middle East & Africa Animal Pharmaceuticals Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value & Volume
11.2. Market Share & Forecast
11.2.1. By Product Type
11.2.2. By Product
11.2.3. By Animal Type
11.2.4. By Country (UAE, Saudi Arabia, Qatar, South Africa)

12. 12
Table of Contents
S. No. Contents Page No.
11.3. Middle East & Africa : Country Analysis
11.3.1. UAE Animal Pharmaceuticals Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value & Volume
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product Type
11.3.1.2.2. By Product
11.3.1.2.3. By Animal Type
11.3.2. Saudi Arabia Animal Pharmaceuticals Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value & Volume
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product Type
11.3.2.2.2. By Product
11.3.2.2.3. By Animal Type
11.3.3. Qatar Animal Pharmaceuticals Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value & Volume
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product Type
11.3.3.2.2. By Product
11.3.3.2.3. By Animal Type

13. 13
Table of Contents
S. No. Contents Page No.
11.3.4. South Africa Animal Pharmaceuticals Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1 By Value & Volume
11.3.4.2. Market Size & Forecast
11.3.4.2.1. By Product Type
11.3.4.2.1. By Product
11.3.4.2.2. By Animal Type
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Pricing Analysis
15. Patent / FDA Approval Analysis
16. Competitive Landscape
16.1. Company Profiles (Top 20 Global Players)
17. Strategic Recommendations
18. About Us & Disclaimer

14. RESEARCHMETHODOLOGY

15. 15
Research Methodology
 Identifying Key Opinion
Leaders
 Questionnaire Design
 In-depth Interviews
Data
Collection
Developing List
of Respondents
Formulating
Questionnaire
Market
Profiling
Data
Validation
Data
Analysis
In-depth secondary
research was conducted to
determine top players in
the global animal
pharmaceuticals market,
overall market size and
segmental market size.
In order to conduct
industry experts’
interviews, TechSci
formulated a detailed
discussion guide.
List of industry
players and industry
specialists was
developed.
TechSci conducted
interviews with
industry experts and
industry players for
data collection and
verification.
Data obtained as a
result of primary
and secondary
research was
validated through
rigorous
triangulation.
The data was scrutinized
using MS-Excel, statistical
tools and internal
proprietary database to
obtain qualitative and
quantitative insights about
the global animal
pharmaceuticals market.
Data
Collection
Data Filter
& Analysis
Research &
Intelligence
Actionable
Insights
Business
Solution
Primary Research Desk Research Company Analysis
 Recent Developments
 Market Changing
Aspects/Dynamics
 Government Policies
 Conclusion
 Market Participants
 Key Strengths
 LinkedIn
 TechSci Internal
Database
 Factiva
 Hoovers
Paid Sources
 Company Websites
 Company Annual
Reports
 White Paper Study
 Financial Reports
 Investor
Presentations
 Regulatory Body
 Associations, etc.
Secondary
Research
Primary Research

16. 16
Research Methodology
Baseline Methodology
Our dedicated team of industry experts has monitored and analyzed various aspects of the global animal pharmaceuticals market. The
segments of this market, while considering the major influencing factors such as the increasing pet adoption and rise in fatal diseases
forecasting, which would enable our clients to take better decisions while planning their strategy to achieve sustainability in the global
Methodology Followed for Calculation of Market Size:
• Market Size by Value: Market size, in terms of value, for the year 2019 was calculated based on information collected through
exhaustive secondary research and primary surveys, with various key opinion leaders/stakeholders, such as animal pharmaceuticals
influencers & end users, industry experts, and other industry participants.
• The team interviewed more than 15 – 20 animal pharmaceuticals companies, 100 – 120 end users, and 15 – 20 industry experts and
animal pharmaceuticals market to obtain the overall market size from 2015 to 2019, which was validated by the Delphi technique.
market size was averaged out, to arrive at the market size data during 2015-2019.

17. 17
Research Methodology
• Respondents were asked about the current and future market growth rates, market shares by product type, by product, by animal type, by registration, by region and by company.
Removing the outlier responses, the geometric mean of growth estimates and provider wise revenue shares generated across various segments were considered, to arrive at the
final revenue shares. Revenue shares generated across various segments were further triangulated from other stakeholders.
Methodology Followed for Calculation of Market Shares:
• Market by product type, by product, by animal type, by registration, by region and by company were calculated based on the responses received through primary surveys with
industry experts, in which the respondents were asked about the market shares or revenue generated from various segments of animal pharmaceuticals markets. The final shares
were calculated by taking the geometric mean of the responses gathered from key opinion leaders after eliminating the outliers.
Methodology Followed for Forecasting:
• TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in SPSS/Tableau Software.
• Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast global animal pharmaceuticals market, TechSci
Research used various forecast techniques such as:
 Moving Average
 Time Series Analysis s
 Regression Analysis
 Econometric and Judgmental Analysis

18. 18
Research Methodology
TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research also used the impact analysis during
short, medium and long term period to estimate the demand and to reach accurate market numbers. It should be noted that the figures compiled are only for the organized market
including market share data. The currency used in the report is the United States Dollar (USD), with the market size indicated in USD million.
Partial List of Companies Interviewed Key Secondary Sources
 Zoetis Inc
 Merck Animal Health
 Vetoquinol SA
 Virbac SA
 Boehringer Ingelheim International GmbH
 Eli Lilly & Co
 Perrigo Co PLC
 Sanofi SA
 Bayer AG
 Elanco Animal Health Inc
 Ceva Sante Animale S.A.
 Covetrus Inc.
 Idexx Laboratories Inc.
 Vetoquinol USA, Inc.
 Norbrook Laboratories, Ltd.
 Huvepharma EOOD
 Adivo GmbH
 Ceva Sant Animale
 Phibro Animal Health Corp.
 World Bank
 TechSci Research Proprietary Database & Knowledge Repository
 Company Annual Reports
 Industry Magazines
 Industry Reports
 News Dailies
 Credible Paid Databases

19. 19
INDUSTRY BRIEF
According to TechSci Research report, “Global Animal Pharmaceuticals Market By Product Type, By Product, By Animal Type, By Registration, By Region, Forecast & Opportunities, 2025”, global
animal pharmaceuticals market is expected to grow at a steady CAGR during the forecast period on account of the prevailing trend of pet adoption, which brings along the responsibility of taking care
of the pet’s health. Another major factor is increasing diseases in animals, whose products like, milk and meat are consumed by the human population. If these animals are not taken care of,
diseases like swine flu are likely to enter the food chain and spread all over world. The indispensability of animal pharmaceuticals is crystal clear as they find their applications in diagnosis, treatment
and curing veterinary diseases. Additionally, rising awareness about various veterinary disorders, besides increasing investments made by the governments and pharma companies in animal
pharmaceuticals are driving the animal pharmaceuticals market, globally. However, certain rules made by government regarding issues like animal testing and approval of new drugs & chemicals
limit the potential growth of the market. Increasing number e-commerce platforms have led to the trend of online business which bring along the risks of the transfer of counterfeit medicines via illegal
distribution channels, thus hampering growth of the market.
The animal pharmaceuticals market is segmented by product type, product, animal type, registration and region. In terms of product type, market can be segmented into vaccine, veterinary and
others, out of which vaccines are likely to have a good growth due to the demand for long-term planning for pet’s health. In terms of product, market can be segmented into ectoparasiticides,
endoparasiticides, anti-inflammatories and bronchodilators out of which, ectoparasiticides held the largest market share in 2019 due to the increase in the ectoparasite-ridden animals. The animal
type segment is further bifurcated into companion and production animals, where companion animals hold the larger share as the governments have now started encouraging pet owners to take care
of their pets, thus, in turn propelling the market for companion animals’ pharmaceuticals.
Major players in global animal pharmaceuticals market include Zoetis Inc, Merck Animal Health, Vetoquinol SA, Zoetis Inc, Virbac SA, Boehringer Ingelheim International GmbH, Eli Lilly & Co, Perrigo
Co PLC, Sanofi SA, Bayer AG, Elanco Animal Health Inc, Ceva Sante Animale S.A., Covetrus Inc., Idexx Laboratories Inc., Vetoquinol USA, Inc., Norbrook Laboratories, Ltd., Huvepharma EOOD,
Adivo GmbH, Ceva Sant Animale, Phibro Animal Health Corp, etc. In order to expand their market share, the companies adopt various strategies like new service launches, collaborations,
introduction of more schemes and many more. As of April 2019, Bayer AG, a German pharmaceutical and life sciences company, joined hands with a biotech company, Adiv GmbH, for the
development of anti-bodies for animal pharmaceuticals. Also, in June 2018, Merck & Co.’s subsidiary of animal health merged with a division of Viscon Hatchery Automation, Vinovo B.V., for the
provision of more efficient ovo vaccination for birds and poultry.
“Asia-Pacific is expected to have the highest growth rate in the upcoming years due to the increasing diseases from animals like swine flu and Ebola, which have also escalated the human death rate
across the globe. Additionally, increasing consumption of dairy products and growing exports of animals to other countries are stressing on the need of maintaining the health of the animals, which is
anticipated to drive animal pharmaceuticals market through 2025.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

20. 20
SAMPLE DATA - SNAPSHOT
5.00 6.00
7.00
8.00
9.00
10.00
11.00 12.00
13.00
14.00
15.00
10.00
20.00
30.00
40.00
50.00 60.00
70.00
80.00
90.00
100.00
110.00
2015 2019 2020E 2025F
By Value (USD Million)
By Volume (Millions)
Global Animal Pharmaceuticals Market Size, By Value (USD Million) & By Volume (Million), 2015-2025F
CAGR By Value & Volume
XX%
CAGR By Value & Volume
YY%
North America Animal Pharmaceuticals Market Share, By Product Type, By Value, 2015–2025F
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
34%
34%
34%
34%
34%
34%
34%
34%
34%
34%
34%
2015
2016
2017
2018
2019
2020E
2021F
2022F
2023F
2024F
2025F
Vaccine Veterinary Others
United States Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2015–2025F
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
2015
2016
2017
2018
2019
2020E
2021F
2022F
2023F
2024F
2025F
Companion Animals Production Animals

21. 21
REPORT ORDERING
License Type Price
Electronic Access - Single User License $4450
Electronic Access - Multi-User License $5450
Custom Research License $9450
To View Sample OR Purchase Report
Report Name: GLOBAL ANIMAL PHARMACEUTICALS MARKET
FORECAST & OPPORTUNITIES
2015 – 2025

22. About Us & Disclaimer
TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in
number of areas to organizations. The company uses innovative business models that focus on improving productivity, while ensuring creation of high-quality
analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ model of a country, regional and global
company activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the market.
Related Reports
• Peru Animal Feed Market By Type (Fodder, Forage, Compound Feed), By Livestock (Swine, Aquatic Animals, Cattle, Poultry, Others), By Raw
Materials (Soya, Canola, Rendered Meal), By Distribution Channel (Store-based v/s Non-Store-based), By Region, Competition, Forecast &
Opportunities, 2025
• Global Pet Food Market By Pet Type (Dog, Cat & Others), By Point of Sale (Store-based Retail & Non-Store-based Retail), By Region, Competition,
Forecast & Opportunities, 2025
The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely,
accurate or complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it
considers reliable and firsthand. However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible
for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the
subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this
document are indicative of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior
approval of TechSci Research.
TechSci Research – North America
708 Third Avenue, Manhattan,
New York, United States
Tel: +1- 646- 360- 1656
Email: sales@techsciresearch.com
www.techsciresearch.com
Disclaimer
TechSci Research – Europe
54, Old brook, Bretton,
Peterborough,
United Kingdom
Email: sales@techsciresearch.com
www.techsciresearch.com
TechSci Research – Asia-Pacific
B – 44, Sector – 57, Noida, National Capital
Region, U.P. - India
Tel: +91-120-4523900
Email: sales@techsciresearch.com
www.techsciresearch.com